Comparison between A B Infrabuild IPO and Earum Pharmaceuticals IPO.
A B Infrabuild IPO is a SME Fixed Price IPO proposed to list at NSE SME while Earum Pharmaceuticals IPO is a SME Fixed Price proposed to list at BSE SME.
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Mark Corporate Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Hem Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of A B Infrabuild IPO is up to ₹12.19 Cr whereas the issue size of the Earum Pharmaceuticals IPO is up to ₹6.31 Cr. The final issue price of A B Infrabuild IPO is ₹29.00 per share and of Earum Pharmaceuticals IPO is ₹36.00 per share.
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹29.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 3000 shares |
| Fresh Issue Size | 42,04,000 shares | 17,52,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.19 Cr | up to ₹6.31 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 42,04,000 shares | 17,52,000 shares |
| Issue Size Total (Amount) | up to ₹12.19 Cr | up to ₹6.31 Cr |
A B Infrabuild IPO opens on Jun 28, 2019, while Earum Pharmaceuticals IPO opens on Jun 21, 2019. The closing date of A B Infrabuild IPO and Earum Pharmaceuticals IPO is Jul 03, 2019, and Jun 26, 2019, respectively.
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 28, 2019 | Jun 21, 2019 |
| Issue Close | Jul 03, 2019 | Jun 26, 2019 |
| Basis Of Allotment (Tentative) | Jul 09, 2019 | Jul 01, 2019 |
| Initiation of Refunds (Tentative) | Jul 10, 2019 | Jul 02, 2019 |
| Credit of Share (Tentative) | Jul 10, 2019 | Jul 03, 2019 |
| Listing date (Tentative) | Jul 12, 2019 | Jul 04, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
A B Infrabuild IPO P/E ratio is , as compared to Earum Pharmaceuticals IPO P/E ratio of .
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |||
|---|---|---|---|---|
| Financials | Company Financials ()
| |||
| Promoter Shareholding (Pre-Issue) | 90.99 | 100 | ||
| Promoter Shareholding (Post-Issue) | 59.19 | 70.04 | ||
| P/E Ratio | ||||
| Market Cap | ₹36.74 Cr. | ₹22.20 Cr. | ||
| ROE | ||||
| ROCE | ||||
| Debt/Equity | ||||
| EPS | ||||
| RoNW |
In the A B Infrabuild IPO Retail Individual Investors (RII) are offered 21,04,000 shares while in Earum Pharmaceuticals IPO retail investors are offered 21,04,000 shares. Qualified Institutional Buyers (QIB) are offered in A B Infrabuild IPO and in Earum Pharmaceuticals IPO.
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,24,000 shares | 96,000 shares |
| QIB | ||
| NII | 21,00,000 shares | 8,76,000 shares |
| RII | 21,04,000 shares | 8,76,000 shares |
| Employee | ||
| Others | ||
| Total | 42,04,000 shares | 17,52,000 shares |
A B Infrabuild IPO subscribed 0.97x in total, whereas Earum Pharmaceuticals IPO subscribed 1.60x.
| A B Infrabuild IPO | Earum Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.20x | 1.72x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.74x | 1.48x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 0.97x | 1.60x |
